On Air Now

Current Show

Show Info »

Upcoming Shows

Program Schedule »

Tune in to Listen

95.7 FM Sioux Falls, SD

Weather

Current Conditions(Sioux Falls,SD 57104)

More Weather »
62° Feels Like: 62°
Wind: WNW 24 mph Past 24 hrs - Precip: 0”
Current Radar for Zip

Today

AM Clouds/PM Sun 87°

Tonight

Isolated Thunderstorms 60°

Tomorrow

Sunny 79°

Alerts

  • 0 Severe Weather Alerts
  • 0 Cancellations

UK cost agency backs Celgene bone marrow drug in change of tack

LONDON (Reuters) - Celgene's drug Revlimid should be an option on Britain's state health service for patients with serious bone marrow disorders and a specific chromosomal abnormality, the country's cost agency said on Wednesday.

The final draft guidance from the National Institute for Health and Care Excellence (NICE) represents a change of tack after the medicine was rejected last year for treating myelodysplastic syndromes, which can lead to life-threatening diseases including leukaemia.

The latest decision follows the submission of revised analyses from Celgene and further information on the company's proposal to limit the cost of the drug. Celgene has agreed to provide Revlimid free of charge for anyone who needs more than 26 monthly cycles of treatment.

The draft guidance is now open for consultation before NICE issues final guidance.

(Reporting by Ben Hirschler; Editing by Pravin Char)

Comments